DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 123 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2016. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $4,923,000 | -56.4% | 1,246,397 | +15.9% | 0.00% | -50.0% |
Q3 2016 | $11,280,000 | -23.6% | 1,075,267 | +6.1% | 0.00% | -33.3% |
Q2 2016 | $14,772,000 | -19.2% | 1,013,173 | +6.6% | 0.00% | -25.0% |
Q1 2016 | $18,293,000 | -23.9% | 950,782 | -4.5% | 0.00% | -33.3% |
Q4 2015 | $24,047,000 | +2.1% | 995,307 | +3.7% | 0.01% | 0.0% |
Q3 2015 | $23,545,000 | +29.7% | 959,461 | +23.8% | 0.01% | +50.0% |
Q2 2015 | $18,152,000 | +3.5% | 774,887 | -0.9% | 0.00% | 0.0% |
Q1 2015 | $17,532,000 | +43.6% | 781,629 | +8.0% | 0.00% | +33.3% |
Q4 2014 | $12,205,000 | – | 723,932 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |